Bevacizumab plus interferon-α versus sunitinib for first-line treatment of renal cell carcinoma in Italy: a cost-minimization analysis (Q42603046)
Jump to navigation
Jump to search
scientific article published on January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab plus interferon-α versus sunitinib for first-line treatment of renal cell carcinoma in Italy: a cost-minimization analysis |
scientific article published on January 2011 |
Statements
1 reference
Bevacizumab plus interferon-α versus sunitinib for first-line treatment of renal cell carcinoma in Italy: a cost-minimization analysis (English)
1 reference
1 reference
Roberto Ravasio
1 reference
Cinzia Ortega
1 reference
Roberto Sabbatini
1 reference
1 January 2011
1 reference
1 reference
31
1 reference
7
1 reference
507-517
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference